Trials / Terminated
TerminatedNCT00276445
Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan
Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan - A Double-Blind Randomized Study
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Meiji University of Oriental Medicine · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
Intravenous- injection of beta-1,3-glucan in human is known to induce T helper type 1 response, while oral uptake did not. It was examined whether superfine dispersed beta-1,3-glucan (SDG) contrived to absorbed by intestinal mucosa would alleviate allergic symptoms by per-oral ingestion
Detailed description
Beta-1,3-glucan made from Japanese mushroom is commercially available for healthy foodstuffs. Allergy patients were orally administrated either SDG (n=30) or non-dispersed beta-1,3-glucan (NDG, n=30) and allergic symptoms were assessed clinically, by the double-blind, placebo-controlled, randomized study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | beta-1,3-glucan |
Timeline
- Start date
- 2004-01-01
- Completion
- 2004-06-01
- First posted
- 2006-01-13
- Last updated
- 2006-11-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00276445. Inclusion in this directory is not an endorsement.